BSEInsider Trading / SAST6h ago · 25 Sept 2026, 01:07 pm

Intimation of closure of Trading Window

Nitco Ltd · 532722

✦ AI Summary

Nitco Ltd has announced the closure of its trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half-year ended September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern5/10
Regulatory Risk5/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Nitco Ltd - 532722 - Closure of Trading Window

Attachments (1)

📄

3d68a9fb-3183-44ac-bc65-959ed2bf8fcd.pdf

pdf

Download →
View document text
NITCO/SE/2026-27/43 September 25, 2026 Corporate Service Department The Listing Department BSE Limited National Stock Exchange of India Limited Jeejeebhoy Towers Exchange Plaza, Bandra Kurla Complex, Bandra Dalal Street, (E), Mumbai – 400 001 Mumbai – 400 051 Script code: 532722 Script code: NITCO Dear Sir/Madam, Subject: Intimation of closure of Trading Window In terms of provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and Company’s Code to regulate, monitor and report trading by insiders, the Trading Window for dealing in securities of NITCO Limited (“the Company”) shall remain closed for designated persons and their immediate relatives from Thursday, October 01, 2026, till the completion of forty-eight (48) hours after the declaration of Unaudited Financial Results (Standalone and Consolidated) of the Company for the Quarter and half year ended September 30, 2026. Kindly take the above intimation on records. Thanking You Yours Sincerely, For NITCO Limited Arihant Kothari Company Secretary and Compliance Officer Membership No.: A81823 Registered Office: NITCO Limited, 3/A, Recondo Compound, Sudam Kalu Ahire Marg, Glaxo, Worli Colony, Mumbai, Maharashtra, India, 400 030. Tel.: 91-22-25772800|25772790. CIN: L26920MH1966PLC016547. Email: investorgrievances@nitco.in Website: www. nitco.in